Evidence map›Paper›PMID 29957235›Full record

ReviewJournal of the American College of Cardiology2018

Cardiovascular Diseases in India Compared With the United States.

Dorairaj Prabhakaran, Kavita Singh, Gregory A Roth, Amitava Banerjee, Neha J Pagidipati, Mark D Huffman

Abstract readComparative StudyReview
In one paragraph

Review in Journal of the American College of Cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dorairaj PrabhakaranPublic Health Foundation of India and Centre for Chronic Disease Control, Gurgaon, India; London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: dprabhakaran@phfi.org.
Kavita SinghPublic Health Foundation of India and Centre for Chronic Disease Control, Gurgaon, India.
Gregory A RothInstitute for Health Metrics and Evaluation and the Division of Cardiology at the University of Washington School of Medicine, Seattle, Washington.
Amitava BanerjeeFarr Institute of Health Informatics, University College London, London, United Kingdom.
Neha J PagidipatiDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina.
Mark D HuffmanDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Funding

Postdoctoral Training in Cardiovascular Clinical ResearchT32HL069749 · NHLBI · DUKE UNIVERSITY · PI MARK, DANIEL B · 2003 to 2023
$6.7M
Acute Coronary Syndrome Quality Improvement in Kerala (ACS QUIK)R00HL107749 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HUFFMAN, MARK D · 2014 to 2016
$744k
NHLBI NIH HHS R00 HL107749NHLBI NIH HHS T32 HL069749Wellcome Trust
6 · The paper itself

Abstract

This review describes trends in the burden of cardiovascular diseases (CVDs) and risk factors in India compared with the United States; provides potential explanations for these differences; and describes strategies to improve cardiovascular health behaviors, systems, and policies in India. The prevalence of CVD in India has risen over the past 2 decades due to population growth, aging, and a stable age-adjusted CVD mortality rate. Over the same time period, the United States has experienced an overall decline in age-adjusted CVD mortality, although the trend has begun to plateau. These improvements in CVD mortality in the United States are largely due to favorable population-level risk factor trends, specifically with regard to tobacco use, cholesterol, and blood pressure, although improvements in secondary prevention and acute care have also contributed. To realize similar gains in reducing premature death and disability from CVD, India needs to implement population-level policies while strengthening and integrating its local, regional, and national health systems. Achieving universal health coverage that includes financial risk protection should remain a goal to help all Indians realize their right to health.

Indexed as

Cardiovascular DiseasesHealth PromotionHumansIndiaMortalityRisk FactorsUnited Statesepidemiologyhealth policyhealth systemsreview

Identifiers

PMID29957235
PMCPMC9755955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.